Dr. Bernice Brempong launches Ghana Pharmaceutical Manufacturing Policy

The Government of Ghana has officially launched the Ghana Pharmaceutical Manufacturing Policy, a strategic initiative designed to bolster local medicine production and significantly reduce the nation's reliance on imported pharmaceuticals. Dr. Bernice Makafui Brempong, the Presidential Coordinator for the Ghana Pharmaceutical Hub, introduced the policy as a critical step toward strengthening national health security and expanding primary healthcare. This cabinet-approved framework aims to transform Ghana into a competitive regional hub for medicine manufacturing by addressing systemic barriers to industrial growth.

The new policy provides a comprehensive roadmap for the industry by addressing key challenges such as financing, infrastructure, raw materials, and investment incentives. A central component of this strategy is the development of the Ghana Pharmaceutical Hub, with its second phase set to be established in the Central Region. This facility will focus specifically on the production of active pharmaceutical ingredients (APIs) and seek to integrate the agricultural sector into the pharmaceutical supply chain to ensure a sustainable flow of raw materials for production.

Beyond industrial growth, the policy is integrated into broader national health objectives, including the Mahama Cares initiative, which focuses on expanding healthcare access and managing non-communicable diseases. Dr. Brempong emphasized that achieving these goals requires robust collaboration between pharmaceutical firms, financial institutions, and government stakeholders. By building a comprehensive ecosystem, the government expects the policy to not only improve health outcomes but also stimulate economic growth through job creation and technical innovation.

As the initiative moves forward, the emphasis shifts from policy formulation to active implementation and attracting private sector investment. Dr. Brempong urged all stakeholders to commit to the development of Ghana’s domestic manufacturing capabilities to ensure long-term sustainability. The successful execution of the policy is expected to position Ghana as a leader in pharmaceutical manufacturing within the West African sub-region, providing affordable and high-quality medicines for its citizens.